Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety of Add-on Therapy With DLBS3233 in Patients With Type-2 Diabetes Mellitus

This study has been completed.
Information provided by (Responsible Party):
Dexa Medica Group Identifier:
First received: November 11, 2011
Last updated: May 24, 2013
Last verified: May 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2013
  Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)